Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Case report

Isolation of Mycobacterium arupense from pleural effusion: culprit or not?

Authors: Xian Zhou, Qiaoling Ruan, Weimin Jiang, Xinyu Wang, Yuan Jiang, Shenglei Yu, Yu Xu, Jing Li, Yangyi Zhang, Wenhong Zhang, Yuekai Hu

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Mycobacterium arupense, first identified in 2006, is a slow-growing nontuberculous mycobacterium (NTM) and an emerging cause of tenosynovitis, potentially associated with immunosuppression. However, unlike the diagnostic value of its isolation from osteoarticular specimens, the significance of detecting M. arupense in respiratory specimens is not yet clear.

Case presentation

To our knowledge, we, for the first time, described the identification of M. arupense from the pleural effusion of an immunocompetent patient, who presented with fever and chylothorax. The symptoms resolved with doxycycline treatment for 45 days and a low-fat, high-protein diet. Follow-up at 14 months showed no relapse.

Conclusions

Because the patient fully recovered without combined anti-NTM treatment, we did not consider M. arupense the etiological cause in this case. This indicates that M. arupense detected in pleural effusion is not necessarily a causative agent and careful interpretation is needed in terms of its clinical relevance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cloud JL, Meyer JJ, Pounder JI, Jost KC Jr, Sweeney A, Carroll KC, Woods GL. Mycobacterium arupense sp. nov., a non-chromogenic bacterium isolated from clinical specimens. Int J Syst Evol Micr. 2006;56(6):1413–8.CrossRef Cloud JL, Meyer JJ, Pounder JI, Jost KC Jr, Sweeney A, Carroll KC, Woods GL. Mycobacterium arupense sp. nov., a non-chromogenic bacterium isolated from clinical specimens. Int J Syst Evol Micr. 2006;56(6):1413–8.CrossRef
2.
go back to reference Abudaff NN, Beam E. Mycobacterium arupense: a review article on an emerging potential pathogen in the Mycobacterium terrae complex. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2017;10:1-5. Abudaff NN, Beam E. Mycobacterium arupense: a review article on an emerging potential pathogen in the Mycobacterium terrae complex. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2017;10:1-5.
3.
go back to reference Heidarieh P, Hashemi-Shahraki A, Khosravi AD, Zaker-Boustanabad S, Shojaei H, Feizabadi MM. Mycobacterium arupense infection in HIV-infected patients from Iran. Int J STD AIDS. 2013;24(6):485–7.CrossRefPubMed Heidarieh P, Hashemi-Shahraki A, Khosravi AD, Zaker-Boustanabad S, Shojaei H, Feizabadi MM. Mycobacterium arupense infection in HIV-infected patients from Iran. Int J STD AIDS. 2013;24(6):485–7.CrossRefPubMed
4.
go back to reference Vasireddy R, Vasireddy S, Brown-Elliott BA, Wengenack NL, Eke UA, Benwill JL, Turenne C, Wallace RJ. Mycobacterium arupense, Mycobacterium heraklionense, and a newly proposed species,“Mycobacterium virginiense” sp. nov., but not Mycobacterium nonchromogenicum, as species of the Mycobacterium terrae complex causing tenosynovitis and osteomyelitis. J Clin Microbiol. 2016;54(5):1340–51.CrossRefPubMedPubMedCentral Vasireddy R, Vasireddy S, Brown-Elliott BA, Wengenack NL, Eke UA, Benwill JL, Turenne C, Wallace RJ. Mycobacterium arupense, Mycobacterium heraklionense, and a newly proposed species,“Mycobacterium virginiense” sp. nov., but not Mycobacterium nonchromogenicum, as species of the Mycobacterium terrae complex causing tenosynovitis and osteomyelitis. J Clin Microbiol. 2016;54(5):1340–51.CrossRefPubMedPubMedCentral
5.
go back to reference Neonakis IK, Gitti Z, Kontos F, Baritaki S, Petinaki E, Baritaki M, Liakou V, Zerva L, Spandidos DA. Mycobacterium arupense pulmonary infection: antibiotic resistance and restriction fragment length polymorphism analysis. INDIAN J MED MICROBI. 2010;28(2):173.CrossRef Neonakis IK, Gitti Z, Kontos F, Baritaki S, Petinaki E, Baritaki M, Liakou V, Zerva L, Spandidos DA. Mycobacterium arupense pulmonary infection: antibiotic resistance and restriction fragment length polymorphism analysis. INDIAN J MED MICROBI. 2010;28(2):173.CrossRef
6.
go back to reference Varghese B, Enani M, Shoukri M, AlThawadi S, AlJohani S, Al-Hajoj S. Emergence of rare species of nontuberculous mycobacteria as potential pathogens in Saudi Arabian clinical setting. PLOS NEGLECT TROP D. 2017;11(1):e5288.CrossRef Varghese B, Enani M, Shoukri M, AlThawadi S, AlJohani S, Al-Hajoj S. Emergence of rare species of nontuberculous mycobacteria as potential pathogens in Saudi Arabian clinical setting. PLOS NEGLECT TROP D. 2017;11(1):e5288.CrossRef
7.
go back to reference Al Hamal Z, Jordan M, Hachem RY, Alawami HM, Alburki AM, Yousif A, Deshmukh P, Jiang Y, Chaftari A, Raad II. Mycobacterium arupense in Cancer patients. Medicine. 2016;95(14):e2691.CrossRefPubMedPubMedCentral Al Hamal Z, Jordan M, Hachem RY, Alawami HM, Alburki AM, Yousif A, Deshmukh P, Jiang Y, Chaftari A, Raad II. Mycobacterium arupense in Cancer patients. Medicine. 2016;95(14):e2691.CrossRefPubMedPubMedCentral
8.
go back to reference Gribetz AR, Damsker B, Marchevsky A, Bottone EJ. Nontuberculous mycobacteria in pleural fluid: assessment of clinical significance. Chest. 1985;87(4):495–8.CrossRefPubMed Gribetz AR, Damsker B, Marchevsky A, Bottone EJ. Nontuberculous mycobacteria in pleural fluid: assessment of clinical significance. Chest. 1985;87(4):495–8.CrossRefPubMed
9.
go back to reference Beam E, Vasoo S, Simner PJ, Rizzo M, Mason EL, Walker RC, Deml SM, Brown-Elliott BA, Wallace RJ, Wengenack NL, et al. Mycobacterium arupense flexor tenosynovitis: case report and review of antimicrobial susceptibility profiles for 40 clinical isolates. J Clin Microbiol. 2014;52(7):2706–8.CrossRefPubMedPubMedCentral Beam E, Vasoo S, Simner PJ, Rizzo M, Mason EL, Walker RC, Deml SM, Brown-Elliott BA, Wallace RJ, Wengenack NL, et al. Mycobacterium arupense flexor tenosynovitis: case report and review of antimicrobial susceptibility profiles for 40 clinical isolates. J Clin Microbiol. 2014;52(7):2706–8.CrossRefPubMedPubMedCentral
10.
go back to reference Tanaka T, Saito N, Takaki M, Furumoto A, Morimoto K, Ariyoshi K. Refractory chylothorax in HIV/AIDS-related disseminated mycobacterial infection. Thorax. 2016;71(10):960–1.CrossRefPubMed Tanaka T, Saito N, Takaki M, Furumoto A, Morimoto K, Ariyoshi K. Refractory chylothorax in HIV/AIDS-related disseminated mycobacterial infection. Thorax. 2016;71(10):960–1.CrossRefPubMed
Metadata
Title
Isolation of Mycobacterium arupense from pleural effusion: culprit or not?
Authors
Xian Zhou
Qiaoling Ruan
Weimin Jiang
Xinyu Wang
Yuan Jiang
Shenglei Yu
Yu Xu
Jing Li
Yangyi Zhang
Wenhong Zhang
Yuekai Hu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3136-3

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue